StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Mereo BioPharma cash

Cash and short-term investments held at the end of each period.

Mereo BioPharma's cash was $26.10M at Sep 30, 2026. For fiscal 2025 it was $40.99M, down 41.3% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$40.99M-41.3%
FY2024Dec 31, 2024$69.80M+21.6%
FY2023Dec 31, 2023$57.42M-15.8%
FY2022Dec 31, 2022$68.18M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$26.10M-46.4%
Q2 FY2026Jun 30, 2026$30.12M-46.3%
Q1 FY2026Mar 31, 2026$30.10M-51.8%
Q4 FY2025Dec 31, 2025$40.99M-41.3%
Q3 FY2025Sep 30, 2025$48.70M-39.5%
Q2 FY2025Jun 30, 2025$56.13M-35.8%
Q1 FY2025Mar 31, 2025$62.48M+28.4%
Q4 FY2024Dec 31, 2024$69.80M+21.6%
Q3 FY2024Sep 30, 2024$80.52M+18.1%
Q2 FY2024Jun 30, 2024$87.43M–
Q1 FY2024Mar 31, 2024$48.66M–
Q4 FY2023Dec 31, 2023$57.42M–
Q4 FY2022Dec 31, 2022$68.18M–

More Mereo BioPharma figures

See a number that looks wrong?